Gene · 1108
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prospective phenotyping of CHAMP1 disorder indicates that coding mutations may not act through haploinsufficiency. | Hum Genet | 2023 | 37454340 | PubTator, text mining | PubMed |
| Prevalence of anti-synthetase antibodies among systemic sclerosis patients. | Eur J Intern Med | 2023 | 37453844 | PubTator, text mining | PubMed |
| Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting. | Cancer Discov | 2023 | 37449843 | PubTator, text mining | PubMed |
| Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1). | Int J Mol Sci | 2023 | 37445725 | PubTator, text mining | PubMed |
| Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities. | Cancers (Basel) | 2023 | 37444571 | PubTator, text mining | PubMed |
| Structures of CTCF-DNA complexes including all 11 zinc fingers. | Nucleic Acids Res | 2023 | 37439339 | PubTator, text mining | PubMed |
| PARP inhibitors: enhancing efficacy through rational combinations. | Br J Cancer | 2023 | 37430137 | PubTator, text mining | PubMed |
| Protocol for generating monoclonal CRISPR-Cas9-mediated knockout cell lines using RNPs and lipofection in HNSCC cells. | STAR Protoc | 2023 | 37421616 | PubTator, text mining | PubMed |
| Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability. | Nat Cell Biol | 2023 | 37414849 | PubTator, text mining | PubMed |
| Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1. | PLoS Pathog | 2023 | 37410772 | PubTator, text mining | PubMed |
| Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders. | Cells | 2023 | 37408271 | PubTator, text mining | PubMed |
| Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. | Cancer Med | 2023 | 37387515 | PubTator, text mining | PubMed |
| Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome. | Cancer Res Commun | 2023 | 37377903 | PubTator, text mining | PubMed |
| Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical. | Molecules | 2023 | 37375228 | PubTator, text mining | PubMed |
| p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells. | Int J Mol Sci | 2023 | 37372954 | PubTator, text mining | PubMed |
| ZNF219, a novel transcriptional repressor, inhibits transcription of the prototype foamy virus by interacting with the viral LTR promoter. | Virus Res | 2023 | 37356580 | PubTator, text mining | PubMed |
| Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids. | Nat Commun | 2023 | 37355690 | PubTator, text mining | PubMed |
| Globally invariant behavior of oncogenes and random genes at population but not at single cell level. | NPJ Syst Biol Appl | 2023 | 37355674 | PubTator, text mining | PubMed |
| Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 37345159 | PubTator, text mining | PubMed |
| Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes. | Front Immunol | 2023 | 37334354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1108/papers?page=13